Epidermal growth factor receptor expression has been shown to be associated with disease recurrence and poor survival in colon cancer (Iqbal and Lenz, 2001; Watanabe et al, 2001; Galizia et al, 2006). Here, EGFR is linked to malignant colon neoplasm.